HKSE - Delayed Quote HKD
Pharmaron Beijing Co., Ltd. (3759.HK)
13.680
+0.160
+(1.18%)
At close: 4:08:06 PM GMT+8
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
23,927,398.321
26,476,712.836
20,492,557.228
18,389,124.353
Total Liabilities Net Minority Interest
9,704,526.037
13,238,666.498
9,652,689.513
8,093,817.610
Total Equity Gross Minority Interest
14,222,872.284
13,238,046.338
10,839,867.715
10,295,306.744
Total Capitalization
17,996,701.790
20,756,462.468
15,002,876.379
14,552,425.993
Common Stock Equity
13,619,333.910
12,556,797.361
10,548,615.357
10,129,240.935
Capital Lease Obligations
401,307.323
585,197.421
760,514.558
284,337.633
Net Tangible Assets
10,067,596.153
8,986,822.964
7,058,215.977
7,340,040.588
Working Capital
3,384,174.255
7,219,937.354
2,623,573.941
5,661,505.505
Invested Capital
18,761,671.832
21,333,533.680
15,665,643.769
14,974,182.509
Tangible Book Value
10,067,596.153
8,986,822.964
7,058,215.977
7,340,040.588
Total Debt
5,975,492.474
9,697,590.579
6,116,522.231
5,285,116.052
Net Debt
3,452,421.840
2,857,821.042
3,619,544.579
1,301,121.874
Share Issued
1,777,786.009
1,786,732.206
1,786,601.443
1,786,898.470
Ordinary Shares Number
1,777,786.009
1,786,732.206
1,786,601.443
1,786,898.470
12/31/2021 - 11/28/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6622.HK Zhaoke Ophthalmology Limited
1.740
+1.16%
1873.HK VIVA BIOTECH
1.510
+4.14%
1530.HK 3SBIO
12.260
+4.07%
2269.HK WuXi Biologics (Cayman) Inc.
23.100
+1.09%
KROS Keros Therapeutics, Inc.
14.26
+0.35%
9926.HK Akeso, Inc.
87.300
+0.11%
NTLA Intellia Therapeutics, Inc.
8.48
+2.05%
REGN Regeneron Pharmaceuticals, Inc.
610.86
+1.36%
BNTX BioNTech SE
104.00
+1.94%
MRNA Moderna, Inc.
27.46
+0.88%